loading
Schlusskurs vom Vortag:
$2.95
Offen:
$2.9
24-Stunden-Volumen:
2.63M
Relative Volume:
0.40
Marktkapitalisierung:
$580.67M
Einnahmen:
$116.33M
Nettoeinkommen (Verlust:
$-209.25M
KGV:
-1.3585
EPS:
-2.12
Netto-Cashflow:
$-135.49M
1W Leistung:
-5.26%
1M Leistung:
-12.73%
6M Leistung:
+164.22%
1J Leistung:
+44.00%
1-Tages-Spanne:
Value
$2.84
$2.97
1-Wochen-Bereich:
Value
$2.78
$3.04
52-Wochen-Spanne:
Value
$0.6925
$3.94

Esperion Therapeutics Inc Stock (ESPR) Company Profile

Name
Firmenname
Esperion Therapeutics Inc
Name
Telefon
734-887-3903
Name
Adresse
3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI
Name
Mitarbeiter
304
Name
Twitter
@esperioninc
Name
Nächster Verdiensttermin
2025-03-04
Name
Neueste SEC-Einreichungen
Name
ESPR's Discussions on Twitter

Vergleichen Sie ESPR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
ESPR
Esperion Therapeutics Inc
2.88 683.29M 116.33M -209.25M -135.49M -2.12
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
126.85 63.97B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.62 42.40B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.335 41.77B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.45 23.54B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
437.13 18.89B 3.08B 1.24B 1.07B 25.61

Esperion Therapeutics Inc Stock (ESPR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-18 Eingeleitet Goldman Neutral
2024-12-17 Eingeleitet Cantor Fitzgerald Overweight
2024-06-20 Herabstufung BofA Securities Neutral → Underperform
2024-01-03 Herabstufung BofA Securities Buy → Neutral
2023-11-20 Fortgesetzt JP Morgan Neutral
2023-08-01 Hochstufung Northland Capital Under Perform → Market Perform
2023-06-15 Hochstufung BofA Securities Underperform → Buy
2023-03-16 Herabstufung BofA Securities Neutral → Underperform
2023-03-16 Herabstufung Northland Capital Market Perform → Under Perform
2023-03-07 Hochstufung Credit Suisse Underperform → Neutral
2023-02-27 Fortgesetzt BofA Securities Neutral
2023-02-24 Hochstufung Jefferies Hold → Buy
2023-02-03 Hochstufung Morgan Stanley Underweight → Equal-Weight
2022-08-03 Herabstufung Credit Suisse Neutral → Underperform
2022-05-05 Hochstufung JP Morgan Underweight → Neutral
2022-03-10 Eingeleitet H.C. Wainwright Buy
2021-10-19 Herabstufung Credit Suisse Outperform → Neutral
2021-10-14 Herabstufung Morgan Stanley Equal-Weight → Underweight
2021-05-05 Herabstufung Stifel Buy → Hold
2021-04-26 Fortgesetzt Credit Suisse Outperform
2021-03-11 Eingeleitet Morgan Stanley Equal-Weight
2021-02-12 Herabstufung Jefferies Buy → Hold
2021-02-09 Herabstufung Goldman Neutral → Sell
2021-01-15 Herabstufung BofA Securities Buy → Neutral
2020-11-10 Hochstufung Credit Suisse Neutral → Outperform
2020-09-29 Fortgesetzt JP Morgan Underweight
2020-08-11 Herabstufung Credit Suisse Outperform → Neutral
2020-04-01 Fortgesetzt BofA/Merrill Buy
2020-03-17 Hochstufung Citigroup Neutral → Buy
2020-02-24 Herabstufung Northland Capital Outperform → Market Perform
2020-02-14 Herabstufung Citigroup Buy → Neutral
2019-09-16 Hochstufung Goldman Sell → Neutral
2019-05-29 Herabstufung Goldman Neutral → Sell
2019-05-06 Hochstufung BofA/Merrill Underperform → Neutral
2019-04-26 Hochstufung Goldman Sell → Neutral
2019-03-13 Hochstufung JP Morgan Underweight → Neutral
2019-01-07 Bestätigt Needham Strong Buy
2018-12-13 Eingeleitet Goldman Sell
2018-10-29 Hochstufung Northland Capital Market Perform → Outperform
2018-10-16 Eingeleitet BTIG Research Buy
2018-08-17 Hochstufung Citigroup Neutral → Buy
2018-07-11 Herabstufung Northland Capital Outperform → Market Perform
2018-05-03 Herabstufung JP Morgan Neutral → Underweight
2018-05-02 Herabstufung BofA/Merrill Buy → Underperform
Alle ansehen

Esperion Therapeutics Inc Aktie (ESPR) Neueste Nachrichten

pulisher
09:21 AM

Esperion Appoints New Chief Commercial Officer - TipRanks

09:21 AM
pulisher
09:06 AM

Esperion appoints John Harlow as chief commercial officer - Investing.com

09:06 AM
pulisher
08:55 AM

Esperion Therapeutics Appoints New Chief Commercial Officer - TradingView

08:55 AM
pulisher
08:13 AM

Esperion Appoints John Harlow as Chief Commercial Officer to Drive Growth and Innovation - Quiver Quantitative

08:13 AM
pulisher
08:00 AM

Esperion (NASDAQ: ESPR) appoints John Harlow CCO; led 85% revenue growth at Melinta - Stock Titan

08:00 AM
pulisher
04:23 AM

Can Esperion Therapeutics Inc. stock double in next 5 years2025 Volatility Report & Safe Capital Preservation Plans - newser.com

04:23 AM
pulisher
04:21 AM

Relative strength of Esperion Therapeutics Inc. in sector analysis2025 Winners & Losers & Fast Entry High Yield Tips - newser.com

04:21 AM
pulisher
03:17 AM

Why retail investors favor Esperion Therapeutics Inc. stockJuly 2025 EndofMonth & Low Risk Entry Point Tips - newser.com

03:17 AM
pulisher
03:07 AM

Smart tools for monitoring Esperion Therapeutics Inc.’s price actionBuy Signal & Safe Capital Investment Plans - newser.com

03:07 AM
pulisher
02:10 AM

Is Esperion Therapeutics Inc. stock reversal real or fakeJuly 2025 Intraday Action & Long-Term Safe Investment Plans - newser.com

02:10 AM
pulisher
01:27 AM

Can Esperion Therapeutics Inc. stock reach $100 price target2025 Biggest Moves & Long-Term Investment Growth Plans - newser.com

01:27 AM
pulisher
01:08 AM

Will Esperion Therapeutics Inc. stock gain from lower inflation2025 Year in Review & Fast Exit and Entry Strategy Plans - newser.com

01:08 AM
pulisher
01:00 AM

Will earnings trigger a reversal in Esperion Therapeutics Inc.July 2025 Update & Safe Entry Point Alerts - newser.com

01:00 AM
pulisher
Nov 03, 2025

Should you wait for a breakout in Esperion Therapeutics Inc.July 2025 Intraday Action & Community Consensus Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How Esperion Therapeutics Inc. stock benefits from global expansion2025 Top Gainers & Technical Pattern Based Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Esperion Therapeutics Inc. stock return to pre crisis levelsQuarterly Market Review & Real-Time Volume Trigger Notifications - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Using AI based signals to follow Esperion Therapeutics Inc.Quarterly Profit Summary & Weekly High Return Stock Forecasts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Esperion Therapeutics Inc. stock outperform international peersJuly 2025 Action & Daily Volume Surge Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Esperion to Participate in Jefferies Global Healthcare ConferenceLondon - The Manila Times

Nov 03, 2025
pulisher
Nov 03, 2025

Esperion (NASDAQ: ESPR) to webcast Nov 18 Jefferies Global Healthcare Conference presentation - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

Can volume confirm reversal in Esperion Therapeutics Inc.Quarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Published on: 2025-11-03 04:49:46 - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Published on: 2025-11-03 03:31:08 - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Esperion Therapeutics Inc. (0ET) stock benefit from mergersMarket Sentiment Report & Technical Analysis for Trade Confirmation - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why analysts raise outlook for Esperion Therapeutics Inc. (0ET) stockTrade Performance Summary & Target Return Focused Stock Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why Esperion Therapeutics Inc. stock is favored by top institutionsPortfolio Update Summary & AI Forecast for Swing Trade Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can Esperion Therapeutics Inc. stock deliver surprise earnings beatMarket Activity Report & Daily Profit Maximizing Trade Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Published on: 2025-11-03 01:10:01 - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why Esperion Therapeutics Inc. is moving todayJuly 2025 Retail & Capital Efficiency Focused Ideas - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

How to integrate Esperion Therapeutics Inc. into portfolio analysis toolsPortfolio Gains Report & Verified Stock Trade Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How high can Esperion Therapeutics Inc. stock goPortfolio Return Summary & Real-Time Buy Signal Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Why analysts remain bullish on Esperion Therapeutics Inc. stock2025 Sector Review & Real-Time Market Sentiment Reports - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Esperion Therapeutics (NASDAQ:ESPR) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat

Nov 02, 2025
pulisher
Nov 01, 2025

Multi asset correlation models including Esperion Therapeutics Inc.Buy Signal & Verified Short-Term Plans - newser.com

Nov 01, 2025

Finanzdaten der Esperion Therapeutics Inc-Aktie (ESPR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$44.73
price up icon 0.71%
drug_manufacturers_specialty_generic RDY
$13.48
price up icon 0.56%
$22.81
price down icon 0.15%
$10.60
price up icon 0.60%
$142.32
price up icon 0.18%
$437.68
price down icon 0.22%
Kapitalisierung:     |  Volumen (24h):